Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Moro

Showing results (291-300 of 333) with videos related to

Pageof 34
Sort By:
Neurochemistry International|April 24, 2012
Daidzein has neuroprotective effects through ligand-binding-independent PPARγ activationO Hurtado, I Ballesteros, M I Cuartero, et al.
Thrombosis and Haemostasis|December 22, 2010
The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcomeRaquel Rodríguez-González, Mónica Millán, Tomás Sobrino, et al.
Stroke|December 1, 2016
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After StrokeIsabel Bravo-Ferrer, María I Cuartero, Juan G Zarruk, et al.
European Journal of Medicinal Chemistry|November 22, 2011
Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke modelMiriam Redondo, Juan G Zarruk, Placido Ceballos, et al.
Clinical Genetics|September 17, 2013
SPG4-related hereditary spastic paraplegia: frequency and mutation spectrum in BrazilM C França, D B Dogini, A D'Abreu, et al.
Stroke|April 22, 2017
Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic StrokeAlicia García-Culebras, Sara Palma-Tortosa, Ana Moraga, et al.
Revista De Neurologia|November 5, 2011
Neurological tests for functional outcome assessment in rodent models of ischaemic strokeJuan G Zarruk, Isaac Garcia-Yebenes, Víctor G Romera, et al.
Frontiers in Aging Neuroscience|February 2, 2026
Early and progressive retinal microglial changes in APP<sup>NL-F/NL-F</sup> mouse model of Alzheimer's disease revealed by an automated image analysis softwareLidia Sánchez-Puebla, Inés López-Cuenca, Miguel A Sánchez-Puebla, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 21, 2021
Influence of metabolic syndrome on post-stroke outcome, angiogenesis and vascular function in old rats determined by dynamic contrast enhanced MRIJesús M Pradillo, Macarena Hernández-Jiménez, María E Fernández-Valle, et al.
Molecular Therapy. Nucleic Acids|April 11, 2022
First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteersMacarena Hernández-Jiménez, Samuel Martín-Vílchez, Dolores Ochoa, et al.
Pageof 34

Showing results (291-300 of 333) with videos related to

Sort By:
Pageof 34
Neurochemistry International|April 24, 2012
Daidzein has neuroprotective effects through ligand-binding-independent PPARγ activationO Hurtado, I Ballesteros, M I Cuartero, et al.
Thrombosis and Haemostasis|December 22, 2010
The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcomeRaquel Rodríguez-González, Mónica Millán, Tomás Sobrino, et al.
Stroke|December 1, 2016
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After StrokeIsabel Bravo-Ferrer, María I Cuartero, Juan G Zarruk, et al.
European Journal of Medicinal Chemistry|November 22, 2011
Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke modelMiriam Redondo, Juan G Zarruk, Placido Ceballos, et al.
Clinical Genetics|September 17, 2013
SPG4-related hereditary spastic paraplegia: frequency and mutation spectrum in BrazilM C França, D B Dogini, A D'Abreu, et al.
Stroke|April 22, 2017
Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic StrokeAlicia García-Culebras, Sara Palma-Tortosa, Ana Moraga, et al.
Revista De Neurologia|November 5, 2011
Neurological tests for functional outcome assessment in rodent models of ischaemic strokeJuan G Zarruk, Isaac Garcia-Yebenes, Víctor G Romera, et al.
Frontiers in Aging Neuroscience|February 2, 2026
Early and progressive retinal microglial changes in APP<sup>NL-F/NL-F</sup> mouse model of Alzheimer's disease revealed by an automated image analysis softwareLidia Sánchez-Puebla, Inés López-Cuenca, Miguel A Sánchez-Puebla, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 21, 2021
Influence of metabolic syndrome on post-stroke outcome, angiogenesis and vascular function in old rats determined by dynamic contrast enhanced MRIJesús M Pradillo, Macarena Hernández-Jiménez, María E Fernández-Valle, et al.
Molecular Therapy. Nucleic Acids|April 11, 2022
First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteersMacarena Hernández-Jiménez, Samuel Martín-Vílchez, Dolores Ochoa, et al.
Pageof 34